✦ LIBER ✦

R2315 Comparison of macrolides, quinolones, and amoxicillin/clavulanic acid for the treatment of patients with acute bacterial exacerbations of chronic bronchitis: a meta-analysis of randomised controlled trials

✍ Scribed by Falagas, M.; Siempos, I.; Korbila, I.; Manta, K.; Dimopoulos, G.

Book ID: 122783481
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 68 KB
Volume: 29
Category: Article
ISSN: 0924-8579
DOI: 10.1016/S0924-8579(07)72154-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P1184 Comparison offirst with second-lin

P1184 Comparison offirst with second-line antibiotics for acute bacterial exacerbations of chronic bronchitis: a meta-analysis of randomised controlled trials

✍ Dimopoulos, G.; Siempos, I.I.; Korbila, I.P.; Manta, K.G.; Falagas, M.E. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Comparison of cefpodoxime proxetil and a

Comparison of cefpodoxime proxetil and amoxicillin/clavulanic acid in the treatment of elderly patients with acute exacerbations of chronic bronchitis and pneumonia

✍ Miguel Angel Salazar Lezama 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 433 KB

Comparison of antibiotics with placebo f

Comparison of antibiotics with placebo for treatment of acute sinusitis: a meta-analysis of randomised controlled trials

✍ Matthew E Falagas; Konstantina P Giannopoulou; Konstantinos Z Vardakas; George D 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 210 KB

Donepezil for the symptomatic treatment

Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta-analysis of individual patient data from randomised controlled trials

✍ Anne Whitehead; Carlos Perdomo; Raymond D. Pratt; Jacqueline Birks; Gordon K. Wi 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 3 views

## Abstract ## Background The objective was to evaluate the efficacy and tolerability of donepezil (5 and 10 mg/day) compared with placebo in alleviating manifestations of mild to moderate Alzheimer's disease (AD). ## Method A systematic review of individual patient data from Phase II and III do